( , ), :
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
See recent WSJ article here Enthusiasts (biohackers?) and some longevity-focused clinicians believe that microdosing these drugs offers benefits beyond weight loss, such as improved metabolic health, glycemic control, reduced systemic inflammation, and potentially even a lower risk of age-related diseases
This review synthesizes current evidence on key nutraceutical classes (e.g., polyphenols, flavonoids, omega-3 fatty acids, probiotics, plant alkaloids), elucidating their molecular mechanisms such as oxidative stress mitigation, immune modulation, gene regulation, and signaling pathway interactions and highlighting therapeutic applications across major chronic conditions
Insulin-like growth factor-1 and carbohydrate metabolism IGF-1 can promote glucose uptake in certain peripheral tissues [137140] in the magnitude of 47 % from that of insulin [141, 142]
Because compounded drugs do not have the guardrails, nor have they been tested in large populations, there are risks associated with them, and they therefore should never be produced on a mass marketing basis except in very limited situations where the FDA has declared a shortage of drugs in high demand